Indian pharma kings loosen family ties at the top
This article was originally published in Scrip
Executive Summary
Leaders from innovator companies have been making the move to Indian generics companies. What does that mean for the evolving industry in the region, and how easy is it to adjust to leading a family business as the outsider? Anju Ghangurde finds out.